Skip to content
DE

Plasma vitamin B6: understanding pyridoxal 5-phosphate (PLP)

Clinical review pending

PLP is a lab value for vitamin B6 status. The article explains possible causes of abnormal results, factors that affect the measurement and the risks of high supplement doses.

Editorial draft. The medical statements were checked editorially against accessible specialist sources and corrected where needed. Clinical sign-off is still pending.

Plasma PLP: the active form of vitamin B6

Plasma vitamin B6 tests usually measure pyridoxal 5′-phosphate, or PLP for short, the active coenzyme form of B6 that circulates in the blood. Cells need PLP for reactions that process amino acids, build neurotransmitters and heme, and release energy reserves from glycogen. Clinically, plasma PLP is the primary status marker for B6; other forms, such as pyridoxal or 4-pyridoxic acid in urine, help round out the picture.

What role vitamin B6 plays in neurotransmitters and amino acids

B6 is a coenzyme for more than a hundred enzymes. In muscle, PLP is bound to the enzyme glycogen phosphorylase and helps release glucose from stored glycogen. In the brain, it makes possible the steps that turn amino acids into serotonin, dopamine and GABA. In the precursor cells of red blood cells, it helps build heme, the oxygen-carrying part of hemoglobin.

PLP in the bloodstream does not only reflect intake; it also shifts with processes in the body. During inflammation or infection, PLP can fall as more of it moves into tissues and loses its phosphate group, a pattern researchers call a “negative acute-phase” response. Increased activity of alkaline phosphatase, for example in pregnancy or with higher bone turnover, can also dephosphorylate PLP. The level then falls even though intake stays the same. A high-protein diet or exercise alone, however, justifies neither a diagnosis of B6 deficiency nor taking high-dose supplements.

Plasma PLP does have clear limits, though. It reflects neither B6 inside cells nor enzyme activity within cells. It shows availability in the blood, which inflammation can lower regardless of food intake.

Through one-carbon metabolism, B6 also influences processes in the blood vessels. It supports enzymes that convert homocysteine into cysteine, working together with folic acid and vitamin B12. This step, called transsulfuration, helps regulate homocysteine levels. Adequate PLP is associated with a more favorable metabolism over the long term. In large studies, however, lowering homocysteine with B vitamins has not consistently reduced cardiovascular events. B6 acts within a larger metabolic network and is not a treatment on its own.

How to interpret a plasma vitamin B6 result

Lab ranges are based on population data. Most labs flag plasma PLP below about 20 nmol/L as low, with a gray zone above it in which adequate supply is likely but not guaranteed. A value above 30 nmol/L has traditionally been used as a sign of adequate supply, but it is not a proven optimization target. NIH Because ranges and methods vary from lab to lab, the reference interval on your report is the right yardstick for this result.

Age, sex, pregnancy, oral contraceptives, alcohol use and inflammation can all shift values for a given intake, which means two people who eat the same way can have different lab results.

High PLP

A high plasma PLP level usually points to recent supplementation, such as a B complex, a high-dose single B6 product or a fortified product taken shortly before the blood draw. In some people, B6 enters the blood quickly after it is taken, so the timing of the blood draw matters. Less often, unusual sample handling or differences between test methods can artificially raise the values.

Taking too much B6 from supplements over a long period can damage sensory nerves. The risk cannot be read off a single PLP cutoff. The EFSA (the European Food Safety Authority) sets the tolerable upper intake level for adults, including pregnant and breastfeeding women, at 12 mg per day from all sources; this is not an intake target. Pay particular attention to the total from several supplements. New tingling or numbness while taking B6 supplements should be checked promptly. EFSA

Low PLP

A low plasma PLP level can be due to low intake, but that is not the only explanation. Inflammation, infection, increased alkaline phosphatase activity and alcohol use can lower PLP regardless of food intake. Certain medications, such as isoniazid and some chelating agents, bind or interfere with B6 and so reduce its functional availability. Some studies also link oral contraceptives with lower PLP.

Malabsorption, restrictive eating habits, dialysis and liver disease can also change how the vitamin is processed and how much is needed. Because B6 is water-soluble and can only be stored to a limited extent, gaps in supply show up relatively quickly. A low PLP level is easier to assess alongside symptoms, eating habits and other lab values such as homocysteine or alkaline phosphatase.

Normal vitamin B6

A result within the lab’s reference range, with no symptoms and no confounding factors such as active inflammation or a high ALP level, generally reflects adequate availability of circulating B6. The trend over time, together with changes in habits, training and health, says more than a single measurement.

What affects plasma B6 levels?

Several factors can push a plasma PLP result up or down, regardless of how much B6 a person takes in:

  • Food processing and cooking: processing and prolonged cooking at high heat reduce the B6 content of foods. Poultry, fish, potatoes, chickpeas and bananas are common dietary sources. How they are prepared affects how much B6 reaches the bloodstream.

  • High protein intake and exercise: B6 is involved in amino acid and glycogen metabolism. This does not imply a blanket need for extra supplements for people who exercise.

  • Oral contraceptives: associated with lower plasma PLP in some studies, probably through effects on B6 metabolism and distribution.

  • Medications: isoniazid and some chelating agents bind or interfere with B6 and so reduce its functional availability. In such cases, B6 levels are often monitored by a doctor alongside treatment.

  • Alcohol: chronic alcohol use impairs the activation of B6 and can lower circulating PLP regardless of intake.

  • Inflammation: PLP is a negative acute-phase reactant. During active inflammation or infection, more of it moves into tissues, lowering the plasma level regardless of nutritional status.

  • Alkaline phosphatase: raised ALP, as seen in pregnancy or with high bone turnover, dephosphorylates PLP in the circulation and reduces measured plasma levels, even when intake is adequate.

  • Sleep and stress: a PLP level is not a test of stress or sleep quality. An abnormal value should be interpreted in light of the established influencing factors.

  • Sample handling: PLP is sensitive to light; for a valid result, the blood sample must be protected from light immediately after it is drawn. Assay differences between labs can also affect the values.

Companion markers for a vitamin B6 test

Plasma PLP is most informative when assessed together with lab values that involve the same metabolic pathways or explain why a result might be shifted:

  • Homocysteine: influenced by B6, B12, folate and kidney function, among other things. High homocysteine together with low PLP does not prove that B6 is the only limiting factor.

  • hs-CRP: hs-CRP marks the acute-phase response, which suppresses plasma PLP regardless of intake. A low PLP with raised CRP may reflect physiological redistribution rather than a true dietary deficiency.

  • Folate: a deficiency can be present at the same time and affect the homocysteine level. A combined finding needs a joint clinical assessment.

  • Vitamin B12: can be tested as well when the question calls for it. Even a panel of several B vitamins does not always clearly explain raised homocysteine.

  • Alkaline phosphatase (ALP): raised ALP from bone turnover or pregnancy dephosphorylates PLP in the circulation and lowers plasma levels regardless of intake. Taking ALP into account prevents a low PLP from being wrongly blamed on an inadequate diet.

When it makes sense to retest plasma B6

PLP can respond to a change in intake, but it is also affected by the most recent supplement dose and by inflammation. Whether a retest is needed, and at what interval, depends on symptoms, the starting value and treatment. A general retest date after 8–12 weeks is not supported for every situation.

The conditions of the blood draw matter for a meaningful result:

  • Because PLP is sensitive to light, the blood sample should be protected from light immediately after it is drawn. Check with the lab doing the blood draw whether this step is part of their procedure.

  • If the goal is to capture your baseline nutrient status, avoid having blood drawn during an acute illness or a period of marked inflammation: inflammation suppresses PLP regardless of intake and makes the result harder to interpret.

  • Pairing the retest with a CRP helps gauge the influence of inflammation and helps distinguish a real, intake-driven change from a physiological one.

When a vitamin B6 result should be discussed with a doctor

In some situations a plasma B6 result calls for a closer look: a PLP below the lab’s reference range, especially together with symptoms such as low mood, tiredness or tingling in the hands or feet; a persistently raised PLP in someone taking high-dose pyridoxine supplements; or a low PLP together with raised homocysteine, where B6 may be the rate-limiting factor in the transsulfuration pathway.

Results in the gray zone just above the deficiency cutoff are best interpreted by looking at the trend. A single borderline value gives less reason to act than a value that falls steadily across successive blood draws. Combining the result with hs-CRP and ALP, as described above, makes it easier to account for possible influencing factors before drawing conclusions about whether nutrient intake is adequate.

A single blood sample is enough for PLP. Preparation depends on the lab; some require a fasting sample and a short break from vitamin supplements. Follow your practice’s specific instructions. A high value without supplements should also be investigated, especially if alkaline phosphatase is low at the same time: this can occur in hypophosphatasia, among other conditions. Lab information

Frequently asked questions

What is plasma vitamin B6, and why is it measured?

Plasma vitamin B6 (measured as pyridoxal 5-phosphate, or PLP) is the active circulating form of vitamin B6 in the blood. It reflects how much B6 is available for enzyme reactions involved in neurotransmitter synthesis, energy metabolism and immune function. The value is a common status marker, but not a direct functional test of every B6-dependent enzyme.

How does vitamin B6 affect energy and brain function?

Vitamin B6 supports many enzymes, including those involved in building neurotransmitters and breaking down glycogen. A marked deficiency can cause neurological and other symptoms. Tiredness or trouble concentrating alone, however, does not show that B6 is lacking; if supply is adequate, more B6 does not automatically improve brain function. NIH

What is the normal range for plasma vitamin B6 (PLP)?

20 nmol/L was used as a marker of adequate supply when dietary recommendations were derived; above 30 nmol/L has also traditionally been considered adequate. These are not thresholds for “optimal” performance. For an individual result, what counts is the lab method, symptoms, supplements and inflammation status. NIH

What causes low vitamin B6 levels?

Low plasma B6 is most often linked to inadequate dietary intake, although plant foods such as chickpeas, potatoes and bananas also supply B6. Chronic inflammation, alcohol use, certain medications (including oral contraceptives and some anti-seizure drugs) and conditions that impair nutrient absorption can lower B6 status.

What are the symptoms of vitamin B6 deficiency?

Symptoms of low B6 can include persistent tiredness, mental fogginess, irritability and low mood. These complaints are nonspecific and prove neither a B6 deficiency nor a disturbance in neurotransmitter production. Peripheral neuropathy (tingling or numbness in the hands and feet) and glossitis (an inflamed tongue) are more pronounced signs that appear with a significant deficiency.

Can vitamin B6 levels be too high?

Yes. High supplement doses over a longer period can cause nerve damage, even below 200 mg per day. The European upper limit for adults is 12 mg per day from all sources; it is not a safe individual threshold for someone who already has symptoms. Food alone does not normally lead to such overdoses. With high PLP and no supplements, alkaline phosphatase should also be taken into account. EFSA Lab information

How often should I test my vitamin B6 level?

For people without symptoms, a routine B6 test is not a necessary part of a general nutrient check. Testing can make sense if a deficiency or overdose is suspected, or with certain conditions or medications. If you have neurological symptoms, seek medical advice promptly rather than waiting for a yearly retest.

Does vitamin B6 affect homocysteine levels?

Yes. B6 is involved in the transsulfuration pathway, which converts homocysteine into cysteine. Folate and B12 work in a different pathway, the conversion of homocysteine back into methionine. A low B6 level can lead to raised homocysteine, which is associated with increased cardiovascular risk. Testing PLP and homocysteine together gives a fuller picture of B vitamin status.

Sources and literature from the original text

Origin and editorial review status

Translated and prepared for Nutrient Desk from the original article. Promotional offers for memberships, newsletters and lab services were removed. The bibliography is kept in its original form for unambiguous identification. Figures and source references were checked editorially to the documented extent. Remaining limitations are listed in the evidence report. This draft is not cleared for indexing.